Next, we compared the ability to differentiate patients with LDA vs AD using ROC curve analysis of soluble B cell factors (Fig. 5B) and conventional biomarkers used to monitor SLE disease activity including anti-dsDNA antibodies, C3 and C4. This evidence concerns the gene C3 and Alzheimer disease.